153 related articles for article (PubMed ID: 35865841)
21. Relationship of differences in immunoglobulin heavy/light chain pairs (Hevylite), selected laboratory parameters and stratification systems in different immunochemical types of multiple myeloma.
Scudla V; Lochman P; Pika T; Minarik J; Zapletalova J; Bacovsky J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):84-93. PubMed ID: 26365929
[TBL] [Abstract][Full Text] [Related]
22. Acute renal failure with lambda light chain-derived crystals in a patient with IgD myeloma.
Toly-Ndour C; Peltier J; Piedagnel R; Coppo P; Sachon E; Ronco P; Rondeau E; Callard P; Aucouturier P
Nephrol Dial Transplant; 2011 Sep; 26(9):3057-9. PubMed ID: 21737515
[TBL] [Abstract][Full Text] [Related]
23. Plasma exchange combined with bortezomib-based chemotherapy is effective for early renal recovery in a patient with IgD-λ type multiple myeloma.
Ueda H; Kuno H; Takahashi D; Katsuma A; Kimura A; Nakashima A; Kato J; Momoki M; Ohba R; Dobashi N; Yamamoto I; Kawamura T; Miyazaki Y; Yokoo T
CEN Case Rep; 2020 May; 9(2):165-172. PubMed ID: 31974826
[TBL] [Abstract][Full Text] [Related]
24. Multiple myeloma with monoclonal IgG and IgD of lambda type exhibiting, under treatment, a shift from mainly IgG to mainly IgD.
Gallart T; Bladé J; Martínez-Quesada J; Sierra J; Rozman C; Vives J
Immunology; 1985 May; 55(1):45-57. PubMed ID: 3922877
[TBL] [Abstract][Full Text] [Related]
25. [Maintenance hemodialysis in IgD- lambda -type multiple myeloma associated with severe renal failure].
Kihara M; Ikeda Y; Shibata K; Masumori S; Ebira H
Nihon Jinzo Gakkai Shi; 1994 Feb; 36(2):177-81. PubMed ID: 8139151
[TBL] [Abstract][Full Text] [Related]
26. [A further case of IgD myeloma (author's transl)].
Daunizeau A; Daunizeau A; Comyn F
Sem Hop; 1979 Dec 8-15; 55(41-42):1941-3. PubMed ID: 231320
[TBL] [Abstract][Full Text] [Related]
27. [Multiple myeloma with D immunoglobulin].
Benchekroun L; Ouzzif Z; Bouabdillah M; Jaouhar N; Aoufir F; Aoufi F; Chabraoui L
Ann Biol Clin (Paris); 2011; 69(5):581-7. PubMed ID: 22008139
[TBL] [Abstract][Full Text] [Related]
28. [IgD myeloma manifesting as acute renal insufficiency].
Duvic C; Sarret D; De Revel T; Hérody M; Didelot F; Labaye J; Nédélec G
Rev Med Interne; 2000 Sep; 21(9):799-803. PubMed ID: 11039177
[TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics and outcomes of IgD myeloma: experience across UK national trials.
Agbuduwe C; Iqbal G; Cairns D; Menzies T; Dunn J; Gregory W; Kaiser M; Owen R; Pawlyn C; Child JA; Davies F; Morgan GJ; Jackson GH; Drayson MT; Basu S
Blood Adv; 2022 Sep; 6(17):5113-5123. PubMed ID: 35790108
[TBL] [Abstract][Full Text] [Related]
30. [The successful use of natural alpha-interferon single therapy in multiple myeloma of IgD (lambda)-type].
Suzuki A; Iwase O; Ohkubo T; Nakano M; Toyama K
Rinsho Ketsueki; 1991 Jan; 32(1):47-51. PubMed ID: 1902271
[TBL] [Abstract][Full Text] [Related]
31. The normal counterpart of IgD myeloma cells in germinal center displays extensively mutated IgVH gene, Cmu-Cdelta switch, and lambda light chain expression.
Arpin C; de Bouteiller O; Razanajaona D; Fugier-Vivier I; Brière F; Banchereau J; Lebecque S; Liu YJ
J Exp Med; 1998 Apr; 187(8):1169-78. PubMed ID: 9547329
[TBL] [Abstract][Full Text] [Related]
32. Pathologic quiz case: an 81-year-old woman with compression fracture and renal failure. Multiple myeloma with a monoclonal serum IgD lambda immunoglobulin.
Poulos CK; Ryder KW
Arch Pathol Lab Med; 2003 Oct; 127(10):1383-4. PubMed ID: 14521448
[No Abstract] [Full Text] [Related]
33. IgD paraproteinemias.
Tichý M; Matĕja F; Urban P; Matuska M
Neoplasma; 1993; 40(1):59-61. PubMed ID: 8350950
[TBL] [Abstract][Full Text] [Related]
34. A case of IgD-lambda myeloma.
Jákó J; Virágh S; Brooser G; Dóbiás G; Domán J; Ottó ; Riskó Z; Szemere P
Haematologia (Budap); 1975; 9(3-4):261-78. PubMed ID: 820613
[TBL] [Abstract][Full Text] [Related]
35. [Light chain escape followed by leukemic transformation in a patient with IgD myeloma].
Hatsuse M; Fuchida S; Okano A; Murakami S; Shimazaki C
Rinsho Ketsueki; 2015 Jan; 56(1):48-50. PubMed ID: 25745970
[TBL] [Abstract][Full Text] [Related]
36. Immunoglobulin D-λ/λ biclonal multiple myeloma: A case report.
He QL; Meng SS; Yang JN; Wang HC; Li YM; Li YX; Lin XH
World J Clin Cases; 2021 Apr; 9(11):2576-2583. PubMed ID: 33889623
[TBL] [Abstract][Full Text] [Related]
37. Differential diagnosis between bone relapse of breast cancer and lambda light chain multiple myeloma: role of the clinical biochemist.
Mastroianni A; Panella R; Morelli D
Tumori; 2019 Dec; 105(6):NP17-NP19. PubMed ID: 30799772
[TBL] [Abstract][Full Text] [Related]
38. [IgD myeloma: an aggressive variant. Description of a clinical case and review of the literature].
Airoldi M; Pelucco L; Lamperti R; Gioia F
Recenti Prog Med; 1993 Jun; 84(6):423-7. PubMed ID: 8516549
[TBL] [Abstract][Full Text] [Related]
39. [IgD/kappa myeloma].
Golenkov AK; German GP; Zlatkina AR; Chernokhvostova EV; Cheredeev AN
Ter Arkh; 1984; 56(11):129-31. PubMed ID: 6441298
[TBL] [Abstract][Full Text] [Related]
40. [Primary amyloidosis associated with IgD-lambda M-proteinemia].
Kimura S; Iwatsuka R; Aoki T; Odawara J; Asada N; Yamakura M; Takeuchi M; Matsue K
Rinsho Ketsueki; 2007 Dec; 48(12):1555-8. PubMed ID: 18203516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
